These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3231099)

  • 41. Purification of activated and heterotrimeric forms of Gq proteins.
    Blank JL; Exton JH
    Methods Enzymol; 1994; 237():174-81. PubMed ID: 7934995
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of the human lymphocyte transformation test to detect a biologically active cholera toxin in Vibrio cholerae culture filtrates].
    Nikolaeva IS; Gaĭlonskaia IN; Ferapontov GK; Astashkin EI
    Vestn Akad Med Nauk SSSR; 1981; (12):62-7. PubMed ID: 7331494
    [No Abstract]   [Full Text] [Related]  

  • 43. Purification of tritium-labeled cholera toxin.
    Banwell JG; Hanke DW; Diedrich D
    Infect Immun; 1978 Aug; 21(2):613-8. PubMed ID: 689738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Inheritance and expression of cholera toxin genes introduced into Vibrio cholerae el tor cells in a hybrid plasmid].
    Smirnova NI; Eroshenko GA; Livanova LF; Mozharov OT; Fil'kova SL; Il'ina TS
    Genetika; 1990 Feb; 26(2):206-14. PubMed ID: 2344953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytolytic toxins of Vibrio vulnificus and Vibrio damsela.
    Kreger AS; Kothary MH; Gray LD
    Methods Enzymol; 1988; 165():176-89. PubMed ID: 3231100
    [No Abstract]   [Full Text] [Related]  

  • 46. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.
    Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR
    Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection and differentiation of the gene for toxin co-regulated pili (tcpA) in Vibrio cholerae non-O1 using the polymerase chain reaction.
    Said B; Smith HR; Scotland SM; Rowe B
    FEMS Microbiol Lett; 1995 Jan; 125(2-3):205-9. PubMed ID: 7875567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular comparison of toxigenic clinical & non-toxigenic environmental strains of Vibrio cholerae O1 Ogawa isolated during an outbreak of cholera in south India.
    Sinha S; Chowdhury P; Chowdhury NR; Kamruzzaman M; Faruque SM; Ramamurthy T; Bhattacharya SK; Yamasaki S; Takeda Y; Nair GB
    Indian J Med Res; 2001 Sep; 114():83-9. PubMed ID: 11873402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human kininogens.
    Müller-Esterl W; Johnson DA; Salvesen G; Barrett AJ
    Methods Enzymol; 1988; 163():240-56. PubMed ID: 3237076
    [No Abstract]   [Full Text] [Related]  

  • 50. Hybrid microarray based on double biomolecular markers of DNA and carbohydrate for simultaneous genotypic and phenotypic detection of cholera toxin-producing Vibrio cholerae.
    Shin HH; Seo JH; Kim CS; Hwang BH; Cha HJ
    Biosens Bioelectron; 2016 May; 79():398-405. PubMed ID: 26735874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha 2-macroglobulin.
    Ishibashi H; Hayashida K; Okubo H
    Methods Enzymol; 1988; 163():485-95. PubMed ID: 2467173
    [No Abstract]   [Full Text] [Related]  

  • 52. [Role of moderate bacteriophage 139 in change in production of cholera toxin in a classic strain of Vibrio cholerae].
    Eroshenko GA; Smirnova NI
    Genetika; 2004 Apr; 40(4):445-53. PubMed ID: 15174276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.
    Miller VL; Mekalanos JJ
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3471-5. PubMed ID: 6374658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Possibility of purifying cholera toxin (choleragen) and its antibodies by an immunosorption method].
    Zakrevskii VI; Efremenko VI; Lobanov VV; Dolmatova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):30-4. PubMed ID: 452780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current developments with cholera vaccines: "Where do we go from here?".
    Finkelstein RA
    Prog Clin Biol Res; 1980; 47():133-42. PubMed ID: 7010372
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic diversity among toxigenic and nontoxigenic Vibrio cholerae O1 isolated from the Western Hemisphere.
    Chen F; Evins GM; Cook WL; Almeida R; Hargrett-Bean N; Wachsmuth K
    Epidemiol Infect; 1991 Aug; 107(1):225-33. PubMed ID: 1879486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification of tetanus toxin and its major peptides.
    Robinson JP
    Methods Enzymol; 1988; 165():85-90. PubMed ID: 3068492
    [No Abstract]   [Full Text] [Related]  

  • 58. Shiga toxin: production and purification.
    Keusch GT; Donohue-Rolfe A; Jacewicz M; Kane AV
    Methods Enzymol; 1988; 165():152-62, 399-401. PubMed ID: 3231098
    [No Abstract]   [Full Text] [Related]  

  • 59. Fibrinogen.
    Fuller GM; Bunzel RJ; Nesbitt JE
    Methods Enzymol; 1988; 163():474-85. PubMed ID: 3237087
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of gamma radiation on the immunobiological and immunochemical properties of cholera exotoxin. IV. The biological and immunochemical properties of purified irradiated choleragen].
    Nedugova GI; Rubtsov IV; Samoĭlenko II
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Sep; (9):90-3. PubMed ID: 6438968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.